These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8931722)

  • 1. Kurasoins A and B, new protein farnesyltransferase inhibitors produced by Paecilomyces sp. FO-3684. II. Structure elucidation and total synthesis.
    Uchida R; Shiomi K; Sunazuka T; Inokoshi J; Nishizawa A; Hirose T; Tanaka H; Iwai Y; Omura S
    J Antibiot (Tokyo); 1996 Sep; 49(9):886-9. PubMed ID: 8931722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kurasoins A and B, new protein farnesyltransferase inhibitors produced by Paecilomyces sp. FO-3684. I. Producing strain, fermentation, isolation, and biological activities.
    Uchida R; Shiomi K; Inokoshi J; Masuma R; Kawakubo T; Tanaka H; Iwai Y; Omura S
    J Antibiot (Tokyo); 1996 Sep; 49(9):932-4. PubMed ID: 8931728
    [No Abstract]   [Full Text] [Related]  

  • 3. Syntheses and absolute structures of novel protein farnesyltransferase inhibitors, kurasoins A and B.
    Sunazuka T; Hirose T; Tian ZM; Uchida R; Shiomi K; Harigaya Y; Omura S
    J Antibiot (Tokyo); 1997 May; 50(5):453-5. PubMed ID: 9207919
    [No Abstract]   [Full Text] [Related]  

  • 4. Andrastins A-C, new protein farnesyltransferase inhibitors produced by Penicillium sp. FO-3929. I. Producing strain, fermentation, isolation, and biological activities.
    Omura S; Inokoshi J; Uchida R; Shiomi K; Masuma R; Kawakubo T; Tanaka H; Iwai Y; Kosemura S; Yamamura S
    J Antibiot (Tokyo); 1996 May; 49(5):414-7. PubMed ID: 8682716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Andrastins A-C, new protein farnesyltransferase inhibitors produced by Penicillium sp. FO-3929. II. Structure elucidation and biosynthesis.
    Uchida R; Shiomi K; Inokoshi J; Sunazuka T; Tanaka H; Iwai Y; Takayanagi H; Omura S
    J Antibiot (Tokyo); 1996 May; 49(5):418-24. PubMed ID: 8682717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Andrastin D, novel protein farnesyltransferase inhibitor produced by Penicillium sp. FO-3929.
    Uchida R; Shiomi K; Inokoshi J; Tanaka H; Iwai Y; Omura S
    J Antibiot (Tokyo); 1996 Dec; 49(12):1278-80. PubMed ID: 9031675
    [No Abstract]   [Full Text] [Related]  

  • 7. Benzimidazolones and indoles as non-thiol farnesyltransferase inhibitors based on tipifarnib scaffold: synthesis and activity.
    Li Q; Li T; Woods KW; Gu WZ; Cohen J; Stoll VS; Galicia T; Hutchins C; Frost D; Rosenberg SH; Sham HL
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2918-22. PubMed ID: 15911281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and conformational analysis of peptide inhibitors of farnesyltransferase.
    Byk G; Lelievre Y; Duchesne M; Clerc FF; Scherman D; Guitton JD
    Bioorg Med Chem; 1997 Jan; 5(1):115-24. PubMed ID: 9043663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel conformationally extended naphthalene-based inhibitors of farnesyltransferase.
    Burns CJ; Guitton JD; Baudoin B; Lelièvre Y; Duchesne M; Parker F; Fromage N; Commerçon A
    J Med Chem; 1997 Jun; 40(12):1763-7. PubMed ID: 9191950
    [No Abstract]   [Full Text] [Related]  

  • 10. Farnesyltransferase inhibitors: a new class of cancer chemotherapeutics.
    Koblan KS; Kohl NE; Omer CA; Anthony NJ; Conner MW; deSolms SJ; Williams TM; Graham SL; Hartman GD; Oliff A; Gibbs JB
    Biochem Soc Trans; 1996 Aug; 24(3):688-92. PubMed ID: 8878827
    [No Abstract]   [Full Text] [Related]  

  • 11. Total synthesis of the hydroxyketone kurasoin A using asymmetric phase-transfer alkylation.
    Andrus MB; Hicken EJ; Stephens JC; Bedke DK
    J Org Chem; 2006 Oct; 71(22):8651-4. PubMed ID: 17064051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-substituted piperazines as constrained amino acids. Application to the synthesis of potent, non carboxylic acid inhibitors of farnesyltransferase.
    Williams TM; Ciccarone TM; MacTough SC; Bock RL; Conner MW; Davide JP; Hamilton K; Koblan KS; Kohl NE; Kral AM; Mosser SD; Omer CA; Pompliano DL; Rands E; Schaber MD; Shah D; Wilson FR; Gibbs JB; Graham SL; Hartman GD; Oliff AI; Smith RL
    J Med Chem; 1996 Mar; 39(7):1345-8. PubMed ID: 8691462
    [No Abstract]   [Full Text] [Related]  

  • 13. Conformational restriction of flexible ligands guided by the transferred noe experiment: potent macrocyclic inhibitors of farnesyltransferase.
    Dinsmore CJ; Bogusky MJ; Culberson JC; Bergman JM; Homnick CF; Zartman CB; Mosser SD; Schaber MD; Robinson RG; Koblan KS; Huber HE; Graham SL; Hartman GD; Huff JR; Williams TM
    J Am Chem Soc; 2001 Mar; 123(9):2107-8. PubMed ID: 11456854
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel lead structures for antimalarial farnesyltransferase inhibitors.
    Kettler K; Sakowski J; Wiesner J; Ortmann R; Jomaa H; Schlitzer M
    Pharmazie; 2005 May; 60(5):323-7. PubMed ID: 15918578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3,8-Diazabicyclo[3.2.1]octan-2-one peptide mimetics: synthesis of a conformationally restricted inhibitor of farnesyltransferase.
    Dinsmore CJ; Bergman JM; Bogusky MJ; Culberson JC; Hamilton KA; Graham SL
    Org Lett; 2001 Mar; 3(6):865-8. PubMed ID: 11263902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RPR 130401, a nonpeptidomimetic farnesyltransferase inhibitor with in vivo activity.
    Vrignaud P; Bissery MC; Mailliet P; Lavelle F
    Ann N Y Acad Sci; 1999; 886():249-51. PubMed ID: 10667231
    [No Abstract]   [Full Text] [Related]  

  • 17. Design, synthesis, and activity of achiral analogs of 2-quinolones and indoles as non-thiol farnesyltransferase inhibitors.
    Li Q; Woods KW; Wang W; Lin NH; Claiborne A; Gu WZ; Cohen J; Stoll VS; Hutchins C; Frost D; Rosenberg SH; Sham HL
    Bioorg Med Chem Lett; 2005 Apr; 15(8):2033-9. PubMed ID: 15808463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of oxa-bridged analogues of farnesyltransferase inhibitor RPR 115135.
    Martin C; Mailliet P; Maddaluno J
    J Org Chem; 2001 Jun; 66(11):3797-805. PubMed ID: 11375000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-thiol farnesyltransferase inhibitors: utilization of the far aryl binding site by 5-cinnamoylaminobenzophenones.
    Mitsch A; Wissner P; Böhm M; Silber K; Klebe G; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2004 Sep; 337(9):493-501. PubMed ID: 15362122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UCF76 compounds, new inhibitors of farnesyltransferase produced by Streptomyces.
    Hara M; Soga S; Shono K; Eishima J; Mizukami T
    J Antibiot (Tokyo); 2001 Feb; 54(2):182-6. PubMed ID: 11302493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.